Cargando…
Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions
Chemotherapy induced peripheral neuropathy (CIPN) is an often severe and debilitating complication of multiple chemotherapeutic agents that can affect patients of all ages, across cancer diagnoses. CIPN can persist post-therapy, and significantly impact the health and quality of life of cancer survi...
Autores principales: | Rodwin, Rozalyn L., Siddiq, Namrah Z., Ehrlich, Barbara E., Lustberg, Maryam B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963873/ https://www.ncbi.nlm.nih.gov/pubmed/35360655 http://dx.doi.org/10.3389/fpain.2022.864910 |
Ejemplares similares
-
A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy
por: Ibrahim, Eiman Y., et al.
Publicado: (2022) -
Editorial: Translational research in neuropathic pain: Current status and future directions
por: Karri, Jay, et al.
Publicado: (2022) -
People's experiences living with peripheral neuropathy: a qualitative study
por: Alkandari, Maryam, et al.
Publicado: (2023) -
Cellular Pathogenesis of Chemotherapy-Induced Peripheral Neuropathy: Insights From Drosophila and Human-Engineered Skin Models
por: Shin, Grace Ji-eun, et al.
Publicado: (2022) -
Keratinocyte Biomarkers Distinguish Painful Diabetic Peripheral Neuropathy Patients and Correlate With Topical Lidocaine Responsiveness
por: Albrecht, Phillip J., et al.
Publicado: (2021)